Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2026

Genmab — Februar 2026

Planlagt Fastgjort Låst Flyttet Genmab
385 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #196

    Ja enig 🙂

    1 Reply Last reply
    0
    • concilladoC Offline
      concilladoC Offline
      concillado
      wrote on sidst redigeret af
      #197

      Det lader til at Danske Bank begynder at tilbagekøbe for GEN nu ;-).... kurs 1850

      1 Reply Last reply
      0
      • M Offline
        M Offline
        mortendrost1
        wrote on sidst redigeret af
        #198

        Såh luner det lidt igen. lad os se om den modreaktion vare ved 🙂

        1 Reply Last reply
        0
        • concilladoC Offline
          concilladoC Offline
          concillado
          wrote on sidst redigeret af
          #199

          Yup, tilbagekøb i et lidt surt marked er lidt som at tisse i bukserne 😄

          1 Reply Last reply
          0
          • G Offline
            G Offline
            gentogen
            wrote on sidst redigeret af
            #200

            A Study of GEN1106 in Participants With Solid Tumors.This is a first-in-human (FIH), open-label, multicenter, dose escalation and expansion trial in participants with urothelial and other cancers who have metastatic disease.https://clinicaltrials.gov/study/NCT07416123?term=genmab&aggFilters=status:not&rank=2

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #201

              William Blair analyst Matt Phipps has reiterated their bullish stance on GMAB stock, giving a Buy rating today. https://www.tipranks.com/news/ratings/genmab-near-term-guidance-miss-offset-by-strong-results-and-blockbuster-late-stage-pipeline-upside-ratings-news

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #202

                Goldman Sachs has lowered its price target for Genmab to 1,771 Danish kroner (previously 1,793), while reiterating its neutral rating

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #203

                  Genmab/AL Sydbank: Investorerne fælder hård dom - fokus bør være på pipelinen https://proinvestor.com/investornyt/1413609/genmab-al-sydbank-investorerne-faelder-hard-dom-fokus-bor-vaere-pa-pipelinen

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #204

                    H.C. Wainwright raised the firm's price target on Genmab to $40 from $39 and keeps a Buy rating

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #205

                      if i would have to guess, i would say that is the ADC @gentogen , GEN1107
                      was a Profound Bio ADC ?

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        gentogen
                        wrote on sidst redigeret af
                        #206

                        sounds reasonable

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #207

                          Genmab fik 79 mio. kr. i betaling fra Novo Nordisk i 2025
                          Genmab fik samlet set 97 mio. dollar – svarende til over 613 mio. kr. – i milepælsbetalinger fra selskabets partnere i 2025. https://medwatch.dk/brancher/Medicinal___Biotek/article19028155.ece

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            gentogen
                            wrote on sidst redigeret af
                            #208

                            Ja, Og godt 4,1 milliarder kroner i royalties fra andet end dara

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #209

                              Charlie Haywood from Bank of America Securities maintained a Buy rating on Genmab A/S, with a price target of DKK2,500

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #210

                                RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer https://www.jnj.com/media-center/press-releases/rybrevant-faspro-amivantamab-and-hyaluronidase-lpuj-receives-u-s-fda-breakthrough-therapy-designation-for-patients-with-advanced-head-and-neck-cancer

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  Pensionisten
                                  wrote on sidst redigeret af
                                  #211

                                  Hvad sker der dog med Genmab? Eneste aktie i porteføljen idag - men den tager i den grad for sig. Hvad er det, der er så galt med Genmab. Kan i forklare det på godt gammeltdags Dansk.
                                  . Jeg fatter det ikke ?

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    Pensionisten
                                    wrote on sidst redigeret af
                                    #212

                                    rettelse: eneste aktie i rødt i porteføljen idag....

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #213

                                      on the AGM agenda : Re item 7 (b) on the agenda: The Board of Directors proposes to reduce the Company’s share capital by nominally DKK 1,900,000 by cancellation of 1,900,000 of the Company’s holding of shares

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        ProinvestorNEWS
                                        wrote on sidst redigeret af
                                        #214

                                        Investorerne køber og sælger aktier hyppigere. De holder på deres aktier i meget kortere tid end man gjorde i "gamle dage". Men hvordan påvirket det markedet? Hansen og Larsen kommer også omkring en mulig AI-disruption i transportsektoren, som har sendt DSV ud i et markant kursfald. Kan de store speditører modstå presset? (00:45 Genmab) https://proinvestor.com/boards/131192

                                        1 Reply Last reply
                                        0
                                        • R Offline
                                          R Offline
                                          Raun
                                          wrote on sidst redigeret af
                                          #215

                                          @Pensionisten - Det eneste der er at sige - markedet har altid ret. Men hold da kæft, hvor er det et vanvittigt scenarie vi har set i Genmab igennem de sidste 3 år... Hvad vi ikke har haft af undskyldninger for at kursen bare er bombet totalt i smadder i den pågældende periode - det er ikke småting.....

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper